These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13922102)

  • 21. Triacetyloleandomycin in the treatment of severe infections in infants and children.
    OZYAZICI A; COHEN HJ; PRIGOT A
    Q Rev Pediatr; 1960; 15():102-9. PubMed ID: 14429613
    [No Abstract]   [Full Text] [Related]  

  • 22. Triacetyloleandomycin (TAO)-its value in acne and certain pyogenic skin eruptions. J.
    LOVEMAN AB; HAMMOND K
    J Ky Med Assoc; 1959 Dec; 57():1507-10. PubMed ID: 13853712
    [No Abstract]   [Full Text] [Related]  

  • 23. [On 47 cases of acute otitis media and their antral and mastoid complications treated by triacetyloleandomycin].
    BONNEFOUS G
    Sem Hop Ther Paris; 1961 Oct; 37():744-7. PubMed ID: 13871032
    [No Abstract]   [Full Text] [Related]  

  • 24. Method of dissolving triacetyloleandomycin for the assay of sensitivity of micro-organisms.
    CZEKALOWSKI JW
    Nature; 1961 Mar; 189():752-3. PubMed ID: 13719066
    [No Abstract]   [Full Text] [Related]  

  • 25. Erythromycin, oleandomycin and triacetyloleandomycin.
    Ross S
    Pediatr Clin North Am; 1968 Feb; 15(1):119-29. PubMed ID: 4867776
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatic dysfunction associated with triacetyloleandomycin and propionyl erythromycin ester lauryl sulfate.
    ROBINSON MM
    Am J Med Sci; 1962 Apr; 243():502-10. PubMed ID: 14492926
    [No Abstract]   [Full Text] [Related]  

  • 27. Falsely elevated values for urinary 17-ketosteroids and 17-hydroxycorticoids associated with ingestion of triacetyloleandomycin.
    NUMEROFF M; PERLMUTTER M; SLATER S
    J Clin Endocrinol Metab; 1959 Oct; 19():1350-2. PubMed ID: 14427898
    [No Abstract]   [Full Text] [Related]  

  • 28. Triacetyloleandomycin with triple sulfa. Its role in the control of staphylococcus and streptococcus infections in the urinary tract.
    CARROLL G; GIBAS D; KARELLOS D
    JAMA; 1960 Nov; 174():1603-5. PubMed ID: 13691064
    [No Abstract]   [Full Text] [Related]  

  • 29. Oleandomycin and triacetyloleandomycin.
    FOLTZ EL
    Pediatr Clin North Am; 1961 Nov; 8():1133-42. PubMed ID: 13893869
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bacteriostatic activity exhibited by oleandomycin, triacetyl oleandomycin and spiramycin on mycobacteria].
    VIALLIER J; AUGAGNEUR J
    C R Seances Soc Biol Fil; 1962; 156():1435-7. PubMed ID: 13997027
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of triacetyloleandomycin on bacterial infections of the respiratory tract.
    WAREMBOURG H
    Antibiot Annu; 1959-1960; 7():816-8. PubMed ID: 13842895
    [No Abstract]   [Full Text] [Related]  

  • 32. Cholestatic hepatitis caused by esters of erythromycin and oleandomycin.
    GILBERT FI
    JAMA; 1962 Dec; 182():1048-50. PubMed ID: 13947810
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the therapeutic effectiveness of sigmamycin in patients with dysentery caused by drug-resistant bacilli].
    AIKAWA K; HARDA M; TOKAO Y; HANADA H
    J Antibiot B; 1962 Oct; 15():298-9. PubMed ID: 14040740
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of triacetyloleandomycin in treatment of infected acne.
    EDELSTEIN AJ
    Pa Med J; 1962 Feb; 65():188-90. PubMed ID: 13889160
    [No Abstract]   [Full Text] [Related]  

  • 35. [MICROBIOLOGICAL STUDIES ON TRIACETYLOLEANDOMYCIN].
    VAKULENKO NA
    Antibiotiki; 1964 Nov; 9():1017-20. PubMed ID: 14320473
    [No Abstract]   [Full Text] [Related]  

  • 36. Triacetyloleandomycin: a report on its use in a general hospital.
    LEFEBVRE M; BELIVEAU D; DESILETS R; SIMARD J; CHARBONNEAU PE; LAFORTUNE L; ROY J
    Antibiot Annu; 1959-1960; 7():755-60. PubMed ID: 14415263
    [No Abstract]   [Full Text] [Related]  

  • 37. [TRIACETYLOLEANDOMYCIN. TREATMENT OF CUTANEOUS INFECTIONS IN CHILDREN. (APROPOS OF 42 CASES)].
    CORCOS V
    Clinique (Paris); 1964 Jan; 59():61-6. PubMed ID: 14132244
    [No Abstract]   [Full Text] [Related]  

  • 38. Experiences with triacetyloleandomycin in a rheumatic fever prophylaxis clinic.
    MOU TW
    Antibiot Annu; 1959-1960; 7():904-7. PubMed ID: 14424692
    [No Abstract]   [Full Text] [Related]  

  • 39. [Blood concentrations of oleandomycin after administration of triacetyloleandomycin].
    Caliò R; Pezzi R; Renzini G
    Gazz Int Med Chir; 1964 Dec; 68(24):Suppl:2540-7. PubMed ID: 5294274
    [No Abstract]   [Full Text] [Related]  

  • 40. [Blood and tissue levels of oleandomycin in man as consequence of administration by oral route of triacetyloleandomycin].
    Liani M; Porzio R; Porzio D
    Antibiotica; 1968 Dec; 6(4):368-74. PubMed ID: 5309023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.